Drawing for BIOVERIS FIRST RESPONDER VACCINE

USPTO serial 76620748

BIOVERIS FIRST RESPONDER VACCINE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
DEFORD, JEFFREY S
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIOVERIS FIRST RESPONDER VACCINE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Monica Riva Talley

MONICA RIVA TALLEY FINNEGAN HENDERSON FARABOW GARRETT ET AL901 NEW YORK AVE NWWASHINGTON, DC 20001-4413UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Reagents and diagnostic preparations for scientific and medical research use; research reagents for industrial use, namely, for food testingACTIVE—
005Diagnostic test kits comprised primarily of biological reagents and instruments for use in the detection of agents causing infectious diseases; diagnostic reagents for clinical or medical laboratory use; pharmaceutical preparations, namely vaccines for the treatment of conditions such as diabetes, infectious diseases, cardiovascular disease, and cancerACTIVE—
009Laboratory apparatus, namely biological, biochemical, and chemical analyzers for research assays; computer software for the operation and control of laboratory apparatus, namely, biological, biochemical, and chemical analyzers for research and diagnostic assays for use in the medical and research fieldsACTIVE—
010Medical diagnostic apparatus, namely, biological, biochemical, and chemical analyzers for medical diagnostic assays and testsACTIVE—
042Medical and scientific research and development services in the fields of drug discovery, drug development, medical diagnostics, and biological detection; diagnostic testing services in the fields of drug development, food safety, and biological detection; consulting services in the fields of biological detection and biological defense; medical and scientific research; food testing servicesACTIVE—
044Medical testing and services for diagnostic purposes; diagnostic testing services in the field of disease diagnosis and treatmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 25, 2006MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 25, 2006ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 22, 2005NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 30, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 10, 2005NPUBNOTICE OF PUBLICATION—
Apr 26, 2005PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 1, 2005ALIEASSIGNED TO LIE—
Mar 29, 2005CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 23, 2005CNEAEXAMINERS AMENDMENT MAILED—
Mar 22, 2005CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 7, 2005CPEAEXAMINER'S AMENDMENT AND/OR PRIORITY ACTION MAILED—
Feb 7, 2005CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Jan 24, 2005DOCKASSIGNED TO EXAMINER—
Nov 30, 2004NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance